The question isn’t whether AI will displace workers, but which workers — and what happens when America’s comfortable laptop ...

Satya Nadella says he cares far less about AGI benchmarks than about real-world impact.The tech industry “became the place we were celebrating ourselves and I just hate it.”He says what ...

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

In a recent interview, Microsoft CEO Satya Nadella emphasised that AI's real test lies in fixing real-world issues, and not just demos.

The announcement comes after FedScoop reported on the General Services Administration’s interest in the tool late last week.

A key clause in Microsoft and OpenAI's deal embodies the raging divide between AGI true believers and those who think it's ...

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Microsoft's new AI system, revealed by CEO Satya Nadella, surpasses human doctors in diagnosing complex medical cases, signaling a major step toward medical superintelligence.

Microsoft CEO Satya Nadella said R1 was the first model he had seen that could match up to OpenAI's. OpenAI CEO Sam Altman called R1 an "impressive model" in January.

Artificial intelligence, although an inevitable part of the future, is still highly debated. Read here to learn more about the pros and cons. ... —Satya Nadella, CEO of Microsoft.